American Society of Hematology

SHERPA: Blue

People

  1. Gerecitano
    Gerecitano
  2. Batlevi
    Batlevi
  3. Hamlin
    Hamlin
  4. Horwitz
    Horwitz
  5. Intlekofer
    Intlekofer
  6. Kumar
    Kumar
  7. Matasar
    Matasar
  8. Moskowitz
    Moskowitz
  9. Moskowitz
    Moskowitz
  10. Noy
    Noy

Groups

  1. Biostatistics Service (5)
  2. Center for Pancreatic Cancer Research (5)
  3. Department of Medicine (5)
  4. Epidemiology and Biostatistics (5)
  5. Hematologic Malignancies, Division of (5)
  6. Bone Marrow Transplant (4)
  7. Center for Hematologic Malignancies (4)
  8. Executive Committee, Center for Hematologic Malignancies (4)
  9. GSK Faculty (4)
  10. Hematologic Malignancies Research (4)
Search Within
  1. "Center for Pancreatic Cancer Research"
  2. "John Gerecitano"
Formats
  1. Meeting Abstract (5)
Groups
  1. Biostatistics Service (5)
  2. Center for Pancreatic Cancer Research (5)
  3. Department of Medicine (5)
  4. Epidemiology and Biostatistics (5)
  5. Hematologic Malignancies, Division of (5)
  6. Bone Marrow Transplant (4)

More Groups

People
  1. John Gerecitano (5)
  2. Alison Moskowitz (4)
  3. Anas Younes (4)
  4. Andrew Intlekofer (4)
  5. Andrew Zelenetz (4)
  6. Anita Kumar (4)

More People

Years
  1. 2017 (1)
  2. 2016 (2)
  3. 2015 (1)
  4. 2005 (1)
Publications
  1. Blood (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of PET staging of follicular lymphoma on treatment outcomes and prognosis
    Meeting Abstract

    Alperovich, A.; Batlevi, C. L.; Intlekofer, A. M.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, M. L.; Moskowitz, A. J.; Gerecitano, J.; Hamlin, P. A.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Outcomes of follicular lymphoma patients by dynamic FLIPI at diagnosis and initial treatment in the post-rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Soumerai, J. D.; Copeland, A. R.; Joffe, E.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Drug-induced cutaneous vasculitis in patients with non-Hodgkin's lymphoma receiving bortezomib: A possible surrogate marker of response
    Meeting Abstract

    Gerecitano, J.; Goy, A.; Macgregor-Cortelli, B.; Neylon, E.; Wright, J.; Esseltine, D.; Schenkein, D.; Gonen, M.; O'Connor, O. A.
    Blood (2005)

    Fulltext@MSK | Save